Strand Life Sciences
Strand Life Sciences is an Indian bioinformatics and computational biology company developing software, analytical tools, and custom technology solutions for life sciences research.
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Strand Life Sciences is an Indian bioinformatics and computational biology company headquartered in Bangalore. Established in October 2000 as Strand Genomics, the company was founded by Professors Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay. Its original identity reflected a focus on genomics, but the business later adopted the Strand Life Sciences name as it expanded across a wider range of life-sciences disciplines. The company develops software and analytical platforms used in areas such as next-generation sequencing, biological data mining, visualization, predictive modeling, and computational chemistry. Its products are designed to help researchers and organizations interpret large and complex datasets, identify biological relationships, and evaluate drug-relevant molecular properties through computational methods. Alongside packaged software, Strand provides custom solutions built around its proprietary intellectual property, allowing the company to adapt its technology to specific research, pharmaceutical, biotechnology, and laboratory requirements. Strand's product portfolio has included Strand NGS, formerly known as Avadis NGS, for analysis of next-generation sequencing data; Avadis, a broader data-mining and visualization platform; and Sarchitect, a computational platform for modeling and predicting properties of molecules relevant to drug discovery. The company's Bangalore research and development organization has also been associated with GeneSpring GX, GeneSpring Workgroup, and Mass Profiler Pro software developed and supported for Agilent Technologies. An earlier product, ArrayAssist, was developed for Stratagene using the Avadis platform, although production ended after Stratagene was acquired by Agilent in 2007. Strand developed a strategic relationship with Agilent Technologies in 2007 to develop and support Agilent's GeneSpring software. The relationship was renewed in 2010, with the stated objective of broadening GeneSpring's application across multiple life-sciences disciplines. These collaborations positioned Strand as an engineering and product-development partner within the scientific software ecosystem rather than solely as a provider of independent research tools. In 2021, Reliance Strategic Business Ventures Limited, a subsidiary of Reliance Industries, acquired a controlling stake in Strand Life Sciences. The transaction placed Strand within the broader Reliance group and represented a significant ownership transition for the company. Strand remains associated with life-sciences software, computational biology, and research-technology services. Publicly available reference material provides limited information about its current executive team, detailed financial performance, geographic revenue mix, and present product release schedule.
History
Strand Life Sciences was founded in October 2000 by Professors Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay. The business was initially registered as Strand Genomics, a name reflecting its early concentration on genomics and computational analysis. As its activities broadened into other areas of life-sciences software and research support, the company adopted the Strand Life Sciences name. From the beginning, Strand's work centered on applying computation to biological and chemical information. Its capabilities included data mining, visualization, predictive modeling, computational biology, and computational chemistry. Rather than limiting itself to a single laboratory application, the company developed reusable software platforms and offered customized solutions based on its own intellectual property. This model enabled Strand to work across research workflows involving genomic data, molecular analysis, and scientific decision support. A significant stage in the company's commercial development came in August 2007, when Strand entered into an agreement with Agilent Technologies. Strand was responsible for developing and supporting Agilent's GeneSpring software, which Agilent had obtained through its acquisition of Silicon Genetics in August 2004. The relationship connected Strand's Bangalore-based research and development capabilities with an established international scientific-instrument and laboratory-technology company. Strand's work for Agilent included products associated with genomic, biological, and mass-spectrometry data analysis. The relationship was renewed in October 2010. The renewed arrangement was intended to extend the scope of GeneSpring across multiple life-sciences disciplines, demonstrating Strand's role as both a software developer and a technology partner. Strand's R&D organization in Bangalore was associated with GeneSpring GX from version 9.0.0 onward, GeneSpring Workgroup from version 7.0.0 onward, and Mass Profiler Pro. The company's Avadis platform provided a foundation for data mining and visualization products, while Sarchitect addressed in-silico modeling and prediction of drug-relevant molecular properties. Strand also developed ArrayAssist for Stratagene using the Avadis platform. That product's production was discontinued after Agilent acquired Stratagene in 2007, illustrating how changes among industry partners could affect individual software lines even as Strand continued developing broader capabilities. In 2021, Reliance Strategic Business Ventures Limited, a subsidiary of Reliance Industries, acquired a controlling stake in Strand Life Sciences. The investment changed the company's ownership structure and placed its technology within the Reliance group. Public reference material does not provide enough information to establish the current management roster, post-acquisition operating structure, financial performance, or a complete account of current products and markets. Strand's documented history nevertheless shows a progression from a genomics-focused startup to a broader provider of bioinformatics, computational biology, scientific software, and customized life-sciences technology solutions.
- 2021
Reliance subsidiary takes control
[1]Reliance Strategic Business Ventures Limited acquired a controlling stake in Strand Life Sciences.
- 2010
Agilent relationship is renewed
[1]Strand and Agilent renewed their agreement and planned to expand GeneSpring's scope across several life-sciences disciplines.
- 2007
Strand begins GeneSpring relationship with Agilent
[1]Strand entered an agreement to develop and support Agilent's GeneSpring software.
- 2007
ArrayAssist production ends after Stratagene acquisition
[1]ArrayAssist, developed for Stratagene on the Avadis platform, was discontinued after Stratagene was acquired by Agilent.
- 2004
Agilent acquires Silicon Genetics
[1]Agilent Technologies acquired Silicon Genetics, whose GeneSpring software later became the subject of Strand's development and support work for Agilent.
- 2000
Strand Genomics is founded
[1]Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay founded the company in October 2000 as Strand Genomics.
Products and positioning
A specialist life-sciences technology company combining bioinformatics, computational biology, scientific data analysis, and custom software development for research and drug-discovery workflows.
Next-generation sequencing analysis software
Strand NGS
Strand NGS, formerly known as Avadis NGS, is a software platform for analyzing next-generation sequencing data. It represents Strand's focus on computational workflows that help life-sciences researchers process and interpret high-volume genomic datasets.
Data mining and visualization software
Avadis
Avadis is a data-mining and visualization platform associated with Strand's software portfolio. It provided analytical and visualization capabilities for scientific data and also served as the technological basis for products developed for external life-sciences companies.
Computational chemistry software
Sarchitect
Sarchitect is a computational platform for modeling and predicting drug-relevant molecular properties in silico. Its purpose is to support research and drug-discovery analysis by applying computational methods before or alongside laboratory experimentation.
Life-sciences research software
GeneSpring GX
GeneSpring GX is a life-sciences analysis product developed and supported by Strand's Bangalore R&D organization for Agilent. The product is associated with analysis of biological and genomic research data.
Collaborative life-sciences software
GeneSpring Workgroup
GeneSpring Workgroup is a GeneSpring-family product associated with Strand's development work for Agilent. Public reference material identifies Strand's R&D division with development from version 7.0.0 onward.
Mass-spectrometry data analysis software
Mass Profiler Pro
Mass Profiler Pro is a scientific data-analysis product associated with Strand's Bangalore R&D work for Agilent. It belongs to the company's history of developing analytical software for life-sciences and laboratory workflows.
Microarray analysis software
ArrayAssist
ArrayAssist was developed for Stratagene using the Avadis platform. Production stopped after Stratagene was acquired by Agilent Technologies in 2007.
Brand decisions
2021
Reliance Strategic Business Ventures acquires controlM&ABackground
Strand had developed a portfolio in bioinformatics, computational biology, and scientific software before the ownership change.
Action taken
Reliance Strategic Business Ventures Limited acquired a controlling stake in Strand Life Sciences.
Aftermath
Strand became part of the broader Reliance Industries group. Public sources do not specify the transaction value or detailed post-acquisition operating plans.
2010
GeneSpring agreement is renewed and broadenedStrategyBackground
Strand and Agilent continued their software-development relationship after the initial 2007 agreement.
Action taken
The companies renewed the agreement and expanded GeneSpring's planned application across multiple life-sciences fields.
Aftermath
The renewal reinforced Strand's position as a scientific-software development partner to an international laboratory-technology company.
2007
Strand partners with Agilent on GeneSpringStrategyBackground
Agilent had acquired Silicon Genetics and its GeneSpring software in 2004. Strand subsequently entered a relationship with Agilent to provide software development and support.
Action taken
Strand agreed to develop and support GeneSpring for Agilent Technologies.
Aftermath
The relationship continued through a renewal in 2010 and expanded the intended scope of GeneSpring across multiple life-sciences disciplines.
Recent events
- 2021
Reliance subsidiary acquires controlling stake in Strand Life Sciences[1]
M&A
Reliance Strategic Business Ventures Limited, a subsidiary of Reliance Industries, acquired a controlling stake in Strand Life Sciences, bringing the bioinformatics company into the Reliance group.
- 2010
Strand and Agilent renew GeneSpring development relationship[1]
Other
Strand and Agilent Technologies renewed their relationship, expanding the intended scope of GeneSpring across multiple life-sciences disciplines.
- 2007
Strand begins GeneSpring development and support agreement with Agilent[1]
Other
Strand entered an agreement with Agilent Technologies to develop and support GeneSpring software, following Agilent's acquisition of Silicon Genetics.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/strand-life-sciences · Editorial policy · How profiles are compiled